Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Exelixis (EXEL) Worth a Look: Stock Up 8.1% in Session

Exelixis, Inc. EXEL was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.29 to $5.19 in the past one-month time frame.

The company witnessed one positive estimate revision over the past 7 days. The Zacks Consensus Estimate, however, remained unchanged over the same time frame. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Exelixis currently has a Zacks Rank #3 (Hold).

A better-ranked stock in the Med-Biomed/Gene industry is Adaptimmune Therapeutics plc ADAP, which sports a Zacks Rank #1 (Strong Buy).

Is EXEL going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
EXELIXIS INC (EXEL): Free Stock Analysis Report
 
ADAPTIMMUNE THR (ADAP): Free Stock Analysis Report
 
To read this article on Zacks.com click here.